Logo

Pfizer Joins Accelrys Crystallography Consortium

Nov 13, 2001

SAN FRANCISCO, Nov. 13 – Pfizer joined Accelrys’ High Throughput Crystallography Consortium, Accelrys announced Tuesday.

Princeton, N.J.-based Accelrys, a subsidiary of Pharmacopeia, created the consortium to explore and validate rapid methods for X-ray structure determination, model building, and structure validation, according to the company.  The agreement with Pfizer covers a number of sites, including Sandwich, UK, Groton, Ann Arbor and La Jolla.

With Pfizer, the consortium’s total membership is 13 companies, including Bristol-Myers Squibb, Genencor, and the Genetics Institute.  

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.